Induction of apoptosis and necrosis by resistance modifiers benzazoles and benzoxazines on tumour cell line mouse lymphoma L5718 Mdr+cells

In Vivo

Volumn 19, Issue 6, 2005, Pages 1087-1092

  Varga, Andras ^a   Aki Sener, Esin ^b   Yalcin, Ismail ^b   Temiz Arpaci, Ozlem ^b   Tekiner Gulbas, Betul ^b   Cherepnev, Georgy ^a   Molnar, Joseph ^c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b ANKARA UNIVERSITY   (Turkey)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Apoptosis; Benzimidazoles; Benzothiazoles; Benzoxazines; Benzoxazoles; Mouse lymphoma; Multidrug resistance; Necrosis

Indexed keywords

12H BENZO[A]PHENOTHIAZINE DERIVATIVE; 2 (4 NITROBENZYL)BENZOXAZOLE; 5 (2 THIENYLCARBOXYAMIDO) 2 PHENYLBENZOXAZOLE; 5 (4 NITROBENZAMIDO) 2 BENZYLBENZOXAZOLE; 5 (4 NITROPHENOXYACETAMIDO) 2 PHENYLBENZOXAZOLE; 6 METHYL 2 (2 CHLOROPHENYL)BENZOXAZOLE; A 9; ANTINEOPLASTIC AGENT; B 11; BD 3; BENZOXAZINE DERIVATIVE; D 24; D 30; D 7; FLUORESCEIN ISOTHIOCYANATE; FUSED HETEROCYCLIC RINGS; INDOLE DERIVATIVE; LIPOCORTIN 5; M 627; MULTIDRUG RESISTANCE PROTEIN 1; PROPIDIUM IODIDE; RHODAMINE 123; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOACCUMULATION; CANCER RESISTANCE; CELL LEVEL; CELL TRANSPORT; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACCUMULATION; DRUG SCREENING; DRUG STRUCTURE; FLOW CYTOMETRY; ION TRANSPORT; LYMPHOMA CELL LINE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN;

EID: 27744570901     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Temiz-Arpaci O, Aki-Sener E, Yalcin I and Altanlar N: Synthesis and microbiological activity of some novel N-[2-(p-substitutedphenyl)-5-benzoxazolyl]-cyclohexyl carboxamide, - cyclohexyl acetamide and -cylohexyl propionamide derivatives. Farmaco 57: 771-775, 2002.
2. Temiz-Arpaci O, Aki-Sener E, Yalcin I and Altanlar N: Synthesis and antimicrobial activity of some 2-[p-substituted-phenyl]benzoxazol-5-yl-arylcarboxyamides. Arch Pharm Med Chem 6: 283-288, 2002.
3. Yildiz-Oren I, Yalcin I, Aki-Sener E and Ucarturk N: Synthesis and structure-activity relationships of new antimicrobial active multisubstituted benzazole derivatives. Eur J Med Chem 39: 291-298, 2004.
4. Yalcin I, Tekiner B, Yildiz-Oren I, Temiz-Arpaci O, Aki-Sener E and Alatanlar N: Synthesis and antimicrobial activity of some novel 2,6,7-trisubstituted-2H-3,4-dihydro-1,4-benzoxazin-3-one derivatives. Ind J Chem 42B: 905-909, 2003.
5. Yildiz Oren I, Tekiner-Gulbas B, Yalcin I, Temiz-Arpaci O, Aki-Sener E and Alatanlar N: Synthesis and antimicrobial activity of new 2-(p-substituted-benzyl]-5-(substituted-carbonyl-amino] benzoxazoles. Arch Pharm Med Chem 337: 402-410, 2004.
6. Plemper RK, Erlandson KJ, Lakdawala AS, Prussia A, Boonsombat J, Aki-Sener E, Yalcin I, Yildiz I, Temiz-Arpaci O, Tekiner B, Liotta DC, Snyder JP and Compans RW: A target site for template-based design of measles virus entry inhibitors. PNAS 101(15): 5628-5633, 2004.
7. Alper S, Temiz-Arpaci O, Sener-Aki E and Yalcin I: Some new bi- and ter-benzimidazole derivatives as topoisomerase I inhibitors. I1 Farmaco 58: 497-507, 2003.
8. Pinar A, Yurdakul P, Yildiz I, Temiz-Arpaci O, Acan NL, Aki-Sener E and Yalcin I: Some fused heterocyclic compounds as eukaryotic topoisomerase II inhibitors. Biochem Biophys Res Commun 317: 670-674, 2004.
9. Shi DF, Bradshaw TD, Wrigley S, McCall CJ, Leieveld P, Fichtner I and Stevens MFG: Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. J Med Chem 39: 3375, 1996.
10. DeLuca M and Kerwin S: The total synthesis of UK-1 Tetrahedron Lett 38: 199-202, 1997.
11. Reynolds MB, DeLuca M and Kerwin S: The novel bis(benzoxazole)cytotoxic natural product UK-1 is a magnesium ion-dependent DNA binding agent and inhibitor of human topoisomerase II. Bioorg Chem 27: 326-337, 1999.
12. Nofal ZM, El-Zahar M and Abd El-Karim SS: Novel coumarin derivatives with expected biological activity Molecules 5: 99-113, 2000.
13. Sato S, Kajiura T, Noguchi M, Takehana K, Kobayashi T and Tsuji T: AJI9561, A new cytotoxic benzoxazole derivative produced by Streptomyces sp. J Antibiotics 54: 102-104, 2001.
14. Perrin L, Rakik A, Yearly S, Baumberger C, Kinlochde Loies S, Pechiere M and Hischel B: Combined therapy with zidovudine and L-697,661 in primary HIV infection. AIDS 10: 1233-1237, 1996.
15. Hutchinson I, Jennings SA, Vishnuvajjala BR, Westwell AD and Stevens M: MFG, antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl) benzothiazole amino acid prodrugs. J Med Chem 45: 744-747, 2002.
16. Cornwell MM, Pastan I and Gottesman MM: Certain calcium channel blockers bind specifically to multidrug resistance human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 262: 2166-2170, 1987.
17. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST and van Oers MH: Annexin V flow cytometric detection of phosphatidyl-serine expression on B cells undergoing apoptosis. Blood 84(5): 1415-1420, 1994.
18. Varga A, Sabat R, Mucsi I, Flores VC, Kaiser HE and Molnar J: Effects of butaclamol, clopenthixol, mepromazine and cannabinol stereoisomers on apoptosis induction. Anticancer Res 21/4A: 2709-2712, 2001.
19. Motohashi N, Sakagami H, Kamata K and Yamamoto Y: Cytotoxicity and differentiation-inducing activity of phenothiazine and benzophenothiazine derivatives. Anticancer Res 11: 1933-1938, 1991.